Molnex (Morphine Hydrochloride Trihydrate)

Morphine Hydrochloride Trihydrate, the active ingredient in Molnex, is an opioid analgesic presented as a sterile injectable solution for epidural, intramuscular and intrathecal use. It provides potent relief of severe acute, postoperative, cancer‑related and chronic pain in adult patients requiring opioid therapy under medical supervision safely.

GNH USA supplies Molnex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved shipments to meet global clinical needs.

Morphine Hydrochloride Trihydrate is an opioid analgesic that acts on the central nervous system to relieve pain. - Severe acute pain: provides rapid, strong analgesia for patients with intense short‑term pain. - Postoperative pain: reduces pain intensity after surgical procedures, facilitating recovery. - Cancer pain: manages persistent malignant pain, improving quality of life. - Chronic pain requiring opioid therapy: offers sustained analgesic effect for long‑term pain management under specialist supervision.

Morphine Hydrochloride Trihydrate may cause a range of adverse reactions, varying from common to serious.

Common Side Effects: - Nausea - Constipation - Drowsiness - Dizziness - Pruritus - Dry mouth

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Allergic reactions including anaphylaxis

When using Morphine Hydrochloride Trihydrate, clinicians should observe several safety measures to minimize risk. - Assess pain level and opioid tolerance: evaluate patient’s prior opioid exposure before initiating therapy. - Monitor respiratory function: observe for signs of respiratory depression, especially after dose changes. - Adjust dose in renal or hepatic impairment: reduce dosage or increase interval as needed. - Avoid use with other central nervous system depressants: limit concurrent benzodiazepines or alcohol. - Store at below 25°C: keep in the original container, protect from moisture and light.

Morphine Hydrochloride Trihydrate can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Concurrent use with other opioids: risk of additive respiratory depression. - MAO inhibitors: can precipitate severe hypertension or serotonin syndrome. - CNS depressants (benzodiazepines, barbiturates, alcohol): heightened sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase morphine plasma levels. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce analgesic effect. - Diuretics (e.g., furosemide): can potentiate hypotensive effects.